News

X-ZELL selected for prestigious MedTech Innovator Accelerator program

Singapore, July 2020 – X-ZELL is one of 20 start-ups to be selected for MedTech Innovator’s 2020 Asia Pacific Accelerator program. Founded in 2013, MedTech Innovator is a Los Angeles-based non-profit organisation specialising in medical technology and digital health,...

Next generation Cryoimmunostaining™ Suite revealed

Singapore, June 2020 – 18 months after premiering at the 2019 Medlab Asia exhibition in Singapore, X-ZELL’s game-changing Cryoimmunostaining™ Suite is about to receive a facelift.  According to X-ZELL’s Head of Medical Devices, Bart Van der Voort, the next generation...

X-ZELL part of Galen Growth’s 2020 HealthTech Cohort

Singapore, May 2020 – X-ZELL is one of 23 start-ups selected to be part of Galen Growth’s inaugural HealthTech Cohort, an acceleration and networking initiative designed to champion healthcare innovation from across Asia. According to Julien de Salaberry, CEO &...

Essex Bio-Technology joins X-ZELL Seed+ Investment Round

Singapore/Hong Kong, April 2020 – Rare cell detection specialist X-ZELL has entered into an investment agreement with Essex Bio-Investment, a wholly owned subsidiary of Essex Bio-Technology Ltd (“EssexBio”). Ranked amongst Asia’s 50 most innovative health technology...

X-ZELL featured in German life science magazine Laborjournal

Freiburg, April 2020 – X-ZELL has been featured in the April edition of Laborjournal, one of Germany’s leading life science publications.    The extensive company profile, penned by science journalist Dr Sigrid März, outlines X-ZELL’s rapid ascent from a small Bangkok...

Interview: Krebs im Blut

Due to the overwhelming response to X-ZELL’s recent Live Sessions tour around Germany, we sat down with X-ZELL Founder & CEO, Dr Sebastian Bhakdi, to interview him in his native language.  Singapur, Februar 2020 – Der deutsche Arzt Dr. Sebastian Bhakdi (44) ist...

X-ZELL Cryoimmunostaining™ technology touring Europe

Brussels, February 2020 – Following the official European launch of X-ZELL’s Cryoimmunostaining™ Suite in November 2019, the Singapore start-up will be holding a series of Live Sessions in 2020 in order to introduce the new technology to some of the leading minds in...

X-ZELL to be featured at Phar-East 2020 in Singapore

Singapore, February 2020 – X-ZELL has been selected as one of 50 start-ups to be featured at the upcoming Phar-East Summit in Singapore. To be held between 30 June and 1 July at the Resorts World Convention Centre on Sentosa – an island just off Singapore’s southern...

X-ZELL selected as Finalist for 2020 Hello Tomorrow Global Challenge

Singapore, January 2020 – Singapore med tech start-up, X-ZELL, has been nominated as a Global Finalist for the 2020 Hello Tomorrow Challenge.  Considered one of the world’s leading deep tech start-up competitions, the Challenge was created to celebrate the “best and...

X-ZELL named global Deep Tech Pioneer by Hello Tomorrow

Singapore, November 2019 – On the back of qualifying for the regional final of the prestigious Hello Tomorrow Challenge, X-ZELL has now been selected as one of Hello Tomorrow’s Deep Tech Pioneers. According to the competition’s organising committee, it received a...

X-ZELL

FIGHTING CANCER,
ONE CELL AT A TIME.

© 2020 X-ZELL INC

Find Us

XZELL HQ